Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

F-Prime Capital Leads $62M Round In Biopharmaceutical Startup

by posted 1year ago 238 views
Genoa Pharmaceuticals Inc. said May 15 that it completed a $62 million Series A round of financing led by F-Prime Capital Partners and Edmond de Rothschild Investment Partners. Also participating were Novo AS, RiverVest Venture Partners, and TPG Biotech.